Glaucoma Neuroprotection Trials Are Practical Using Visual Field Outcomes
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference17 articles.
1. Oral memantine for the treatment of glaucoma: design and results of 2 randomized, placebo-controlled, phase 3 Studies;Weinreb;Ophthalmology,2018
2. Improving the feasibility of glaucoma clinical trials using trend-based visual field progression end points;Wu;Ophthalmology Glaucoma,2019
3. Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling;Osborne;Cell Death Dis,2018
4. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial;Leske;Arch Ophthalmol,2003
5. Automated telecommunication-based reminders and adherence with once-daily glaucoma medication dosing: the automated dosing reminder study;Boland;JAMA Ophthalmol,2014
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Endpoints for clinical trials in ophthalmology;Progress in Retinal and Eye Research;2023-11
2. Validating Trend-Based End Points for Neuroprotection Trials in Glaucoma;Translational Vision Science & Technology;2023-10-31
3. Five-Year Visual Field Outcomes of the HORIZON Trial;American Journal of Ophthalmology;2023-07
4. Improving the Power of Glaucoma Neuroprotection Trials Using Existing Visual Field Data;American Journal of Ophthalmology;2021-09
5. Glaucoma Home Monitoring Using a Tablet-Based Visual Field Test (Eyecatcher): An Assessment of Accuracy and Adherence Over 6 Months;American Journal of Ophthalmology;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3